Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells
Joshua M Gammon, Emily A Gosselin, Lisa H Tostanoski, et al.
Cell Reports
|
September 15, 2016
Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific
Lisa H Tostanoski, Yu-Chieh Chiu, Joshua M Gammon, et al.
Biomaterials Science
|
July 7, 2022
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination
James I Andorko, Shannon J Tsai, Joshua M Gammon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 31, 2025
Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response
Shannon J Tsai, Senta M Kapnick, Sean T Carey, et al.
Nature Communications
|
February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation
Joshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Nature Biotechnology
|
January 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Geoffrey M Lynn, Christine Sedlik, Faezzah Baharom, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells
Joshua M Gammon, Emily A Gosselin, Lisa H Tostanoski, et al.
Cell Reports
|
September 15, 2016
Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific
Lisa H Tostanoski, Yu-Chieh Chiu, Joshua M Gammon, et al.
Biomaterials Science
|
July 7, 2022
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination
James I Andorko, Shannon J Tsai, Joshua M Gammon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 31, 2025
Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response
Shannon J Tsai, Senta M Kapnick, Sean T Carey, et al.
Nature Communications
|
February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation
Joshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Nature Biotechnology
|
January 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Geoffrey M Lynn, Christine Sedlik, Faezzah Baharom, et al.
Page
of 2